Ocular Hypertension Is One Of The Most Important Risk Factors Of Glaucoma.

Please connect at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 844-464-3934 (U.S.) or 765-507-2620 (International) to listen to the conference call. The conference ID number for the live call will be 8389302. An archive of the webcast will be available until November 23, 2016 on the Companys website. About Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. ( OCUL ) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Ocular Therapeutix has submitted an NDA for post-surgical pain for its lead product candidate, DEXTENZA (dexamethasone insert), which is in Phase 3 clinical development for post-surgical ocular inflammation and pain and allergic conjunctivitis. OTX-TP (travoprost insert) is in Phase 3 clinical development for glaucoma and ocular hypertension. Ocular Therapeutix is also evaluating injectable drug delivery depots for back-of-the-eye diseases.

For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/ocular-therapeutix-hold-third-quarter-120000509.html

The surgery usuanlly takes 15-20 minutes, and the patient is able to see clearly once again. no dataThe treatment of congenital glaucoma should start as early as possible, to prevent loss of vision. Glaucoma eye problems can be due to the following causes: Blockage of drain canals in the eye, thus resulting in excess aqueous humour in the eye Physical injury to eye or the nerves Some people are prone to this disease due to hereditary In primary open-angle glaucoma, peripheral vision is gradually lost and in the later stages, there is an onset of tunnel vision. Closed angle glaucoma is associated with the blockage present at the iris and cornea joint. After the drop falls into the pocket, close your eyes very gently. Ocular hypertension is one of the most important risk factors of glaucoma. You’ll have to get yourself tested at an ophthalmologist, who’ll recommend you glass or contact lenses to correct your vision. This is achieved by means of cryotherapy or laser therapy. Lumigan is a FDA approved prostaglandins prescribed for this disorder. Pain in the eyes, nausea, vomiting, headache, blurred vision, loss of vision, etc., are some of the most commonly observed symptoms. http://www.theprimitiveoldecrow.com/stellawrightme/2016/11/04/basic-answers-on-effective-secrets-for-retinal-detachment/Glaucoma is an eye condition that is characterized by increased intra ocular pressure that can even lead to impaired vision in the absence of prompt treatment. Keratitis is an eye condition, leading to inflammation of the cornea. Other causes are certain eye infections such as conjunctivitis, blepharitis, corneal ulcers resulting from a viral or bacterial infection, iritis, and uveitis.

These sinuses produce mucus a semi liquid substance that traps dust particles, entering the airways while breathing. This in turn, prevents the flow of aqueous humour through the trabecular mesh work, leading to an increase in the intra ocular pressure. More studies are required to conclude about the effect of psychological stress on intra ocular pressure. Average GOP is 15.5 mm Hg; however, it is not constant. This condition is also known as hordeolum. Closed-angle: This is a rare form, and is also known as acute glaucoma. Conventional medications for glaucoma can lead to various side effects. John’s Mort, to it. Closed angle glaucoma or acute glaucoma is one of the four types of eye diseases that come under glaucoma. Liquid discharge from the eye may also be noticed, apart from the eyes beginning to look cloudy.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>